Literature DB >> 2156175

Protection by verapamil and nifedipine against ischaemia-induced loss of [3H]-(+)-PN 200-110 binding sites in the rat heart.

F T van Amsterdam1, M S van Amsterdam-Magnoni, M Haas, N C Punt, J Zaagsma.   

Abstract

We have studied the effects of 60 min global ischaemia and 30 min of subsequent reperfusion on the binding of [3H]-(+)-PN 200-110 and [3H]-(-)-devapamil (desmethoxyverapamil or D888) in rat heart membranes. The hearts were perfused in the Langendorff-mode and pretreated with 1 mumol/l verapamil, 30 nmol/l and 1 mumol/l nifedipine. After 60 min of global ischaemia in the absence of drugs, we found a reduction of [3H]-(+)-PN 200-110 binding sites, without changes in the equilibrium dissociation binding constant (Kd). After the subsequent reperfusion maximum specific binding (Bmax) was further reduced, whereas the Kd remained constant. [3H]-devapamil binding sites were influenced to a lower extend and showed only a decrease in Bmax at reperfusion. Pretreatment with 1 mumol/l verapamil completely prevented the changes which were observed for [3H]-(+)-PN 200-110. Pretreatment with a low, vasodilating concentration (30 nmol/l) of nifedipine displayed selective protection against the extra reduction in Bmax which was observed during reperfusion. It is concluded that calcium antagonists show protection against the ischaemia-induced loss of dihydropyridine binding sites in relation to their negative inotropic, energy-saving activity. Furthermore, nifedipine at low, vasodilating but not negative inotropic concentrations protects against further reperfusion-induced injury, which protection may be related to an improved flow during reperfusion.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2156175     DOI: 10.1007/BF00195070

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  37 in total

Review 1.  Calcium antagonism in heart and vascular smooth muscle.

Authors:  A Fleckenstein
Journal:  Med Res Rev       Date:  1985 Oct-Dec       Impact factor: 12.944

Review 2.  Amphipathic metabolites and membrane dysfunction in ischemic myocardium.

Authors:  P B Corr; R W Gross; B E Sobel
Journal:  Circ Res       Date:  1984-08       Impact factor: 17.367

3.  High and low affinity states of the dihydropyridine and phenylalkylamine receptors on the cardiac calcium channel and their interconversion by divalent cations.

Authors:  J Ptasienski; K K McMahon; M M Hosey
Journal:  Biochem Biophys Res Commun       Date:  1985-06-28       Impact factor: 3.575

4.  [3H]-nitrendipine binding in membranes obtained from hypoxic and reoxygenated heart.

Authors:  R Matucci; F Bennardini; M L Sciammarella; C Baccaro; I Stendardi; F Franconi; A Giotti
Journal:  Biochem Pharmacol       Date:  1987-04-01       Impact factor: 5.858

5.  Voltage-sensitive nitrendipine binding in an isolated cardiac sarcolemma preparation.

Authors:  W P Schilling; J A Drewe
Journal:  J Biol Chem       Date:  1986-02-25       Impact factor: 5.157

6.  High affinity specific [3H](+)PN 200-110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heart.

Authors:  H R Lee; W R Roeske; H I Yamamura
Journal:  Life Sci       Date:  1984-08-13       Impact factor: 5.037

7.  An effect of ischemia on myocardial dihydropyridine binding sites.

Authors:  W G Nayler; J S Dillon; J S Elz; M McKelvie
Journal:  Eur J Pharmacol       Date:  1985-09-10       Impact factor: 4.432

8.  The effect of hypoxia and of energy depletion on 1,4-dihydropyridine binding sites in rat cardiac membrane fragments.

Authors:  X H Gu; J S Dillon; W G Nayler
Journal:  Biochem Pharmacol       Date:  1989-06-15       Impact factor: 5.858

9.  A low concentration of nisoldipine reduces ischemic heart injury: enhanced reflow and recovery of contractile function without energy preservation during ischemia.

Authors:  J A Watts; J P Whipple; A A Hatley
Journal:  J Mol Cell Cardiol       Date:  1987-08       Impact factor: 5.000

10.  Dynamic and kinetic differences of the vascular and myocardial effects of calcium antagonists in the rat heart.

Authors:  F T van Amsterdam; M Haas; J Zaagsma
Journal:  J Cardiovasc Pharmacol       Date:  1987-05       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.